August 5, 2008Recalls and Safety Alerts: Cellcept and Myfortic Linked to Birth Defects and Fetal Loss Recalls and Safety Alerts: Cellcept and Myfortic Linked to Birth Defects and Fetal Loss
FDA is advising healthcare professionals about an increased risk of fetal harm when women become pregnant while being treated with the immunosuppressant drugs Cellcept (mycophenolate mofetil) or Myfortic (mycophenolic acid). Myfortic is approved t... Recalls and Safety Alerts: Possible Association between TNF Blockers and Cancer FDA has informed healthcare professionals that it is investigating a possible association between drugs that block tumor necrosis factor (TNF) and the development of lymphoma and other cancers in children and young adults. This is part of FDA's ... # posted by Network @ 1:00 AM
 |
Subscribe to Posts [Atom]